12/05/2014
http://accessmarketintell.com/product/distribution-decision-making-for-specialty-drugs/
Distribution Decision-Making for Specialty Drugs
Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market.
Specialty pharmaceuticals tend to be more complex to maintain, administer, and monitor than traditional drugs. The pharma manufacturer must make a distribution strategy decision when launching a new product.
Always a hot button, there is renewed interest in options or considerations for drug distribution of specialty drugs. AMI’s new report offers insight on the decision-making process for specialty drugs through a combination of primary and secondary research.
Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market.